Genetic surveillance of first- and second-line drug-resistant isolates of Mycobacterium tuberculosis in Peru
David Santos-Lázaro, Aiko N Vigo, Vidia V Cotrina, Sandra Villar, Alexis Medina, Cynthia Julcapoma, Edson Pacheco, Miriam J Alarcón · 2026
Read Genetic surveillance of first- and second-line drug-resistant isolates of Mycobacterium tuberculosis in Peru by David Santos-Lázaro, Aiko N Vigo, Vidia V Cotrina, Sandra Villar, Alexis Medina, Cynthia Julcapoma, Edson Pacheco, Miriam J Alarcón (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352881.txt.
Description
Santos-Lázaro and colleagues ran nationwide genetic surveillance of drug-resistant tuberculosis in Peru in a 2026 study. Peru carries the highest burden of multi-drug-resistant tuberculosis in the Americas. Tens of thousands of routine lab assay results from 2019 to 2022 were combined into genotype patterns for first- and second-line drug resistance.
Deeper sequencing of a chosen sample checked cases where resistance was only inferred. Mapping patterns by region shows where resistant strains cluster and spread. Surveillance at this scale helps health officials target testing and drug stocks. It also warns early when new resistance patterns emerge in a high-burden country.
Catalog record
| CREATOR | David Santos-Lázaro, Aiko N Vigo, Vidia V Cotrina, Sandra Villar, Alexis Medina, Cynthia Julcapoma, Edson Pacheco, Miriam J Alarcón |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35648 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |